These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 34103164)

  • 1. Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia.
    Suna K; Melahat UŞ; Murat Y; Figen ÖE; Ayperi Ö
    Med Clin (Barc); 2022 Apr; 158(8):356-360. PubMed ID: 34103164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia.
    Suna K; Melahat UŞ; Murat Y; Figen ÖE; Ayperi Ö
    Med Clin (Engl Ed); 2022 Apr; 158(8):356-360. PubMed ID: 35601360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study".
    Entrenas Castillo M; Entrenas Costa LM; Vaquero Barrios JM; Alcalá Díaz JF; López Miranda J; Bouillon R; Quesada Gomez JM
    J Steroid Biochem Mol Biol; 2020 Oct; 203():105751. PubMed ID: 32871238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness of high-dose intravenous vitamin C for patients with coronavirus disease 2019: A systematic review and meta-analysis.
    Kwak SG; Choo YJ; Chang MC
    Complement Ther Med; 2022 Mar; 64():102797. PubMed ID: 34953366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin C as prophylaxis and adjunctive medical treatment for COVID-19?
    Feyaerts AF; Luyten W
    Nutrition; 2020; 79-80():110948. PubMed ID: 32911430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation into the Effects of Intravenous Vitamin C on Pulmonary CT Findings and Clinical Outcomes of Patients with COVID 19 Pneumonia A Randomized Clinical Trial.
    Tehrani S; Yadegarynia D; Abrishami A; Moradi H; Gharaei B; Rauofi M; Maghsoudi Nejad F; Sali S; Khabiri N; Abolghasemi S
    Urol J; 2022 Dec; 19(6):460-465. PubMed ID: 34746999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia.
    Yildirim F; Karaman I; Şimşek M
    Med Clin (Barc); 2022 Aug; 159(4):e25-e26. PubMed ID: 35039170
    [No Abstract]   [Full Text] [Related]  

  • 11. Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19).
    Colunga Biancatelli RML; Berrill M; Catravas JD; Marik PE
    Front Immunol; 2020; 11():1451. PubMed ID: 32636851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficiency and safety of high-dose vitamin C in patients with COVID-19: a retrospective cohort study.
    Gao D; Xu M; Wang G; Lv J; Ma X; Guo Y; Zhang D; Yang H; Jiang W; Deng F; Xia G; Lu Z; Lv L; Gong S
    Aging (Albany NY); 2021 Feb; 13(5):7020-7034. PubMed ID: 33638944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin C-An Adjunctive Therapy for Respiratory Infection, Sepsis and COVID-19.
    Holford P; Carr AC; Jovic TH; Ali SR; Whitaker IS; Marik PE; Smith AD
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33297491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
    Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
    Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential benefit of high-dose intravenous vitamin C for coronavirus disease 2019 pneumonia.
    Zhao B; Li M; Ling Y; Peng Y; Huang J; Qu H; Gao Y; Li Y; Hu B; Lu S; Lu H; Zhang W; Mao E
    Chin Med J (Engl); 2022 Jan; 135(1):23-25. PubMed ID: 34873081
    [No Abstract]   [Full Text] [Related]  

  • 17. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
    Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
    Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial.
    Sharma A; Sharma C; Raina S; Singh B; Dadhwal DS; Dogra V; Gupta S; Bhandari S; Sood V
    Trials; 2021 Jul; 22(1):451. PubMed ID: 34266452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose intravenous vitamin C decreases rates of mechanical ventilation and cardiac arrest in severe COVID-19.
    Hess AL; Halalau A; Dokter JJ; Paydawy TS; Karabon P; Bastani A; Baker RE; Balla AK; Galens SA
    Intern Emerg Med; 2022 Sep; 17(6):1759-1768. PubMed ID: 35349005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between 25(OH) vitamin D levels and COVID-19 onset and disease course in Spanish patients.
    Diaz-Curiel M; Cabello A; Arboiro-Pinel R; Mansur JL; Heili-Frades S; Mahillo-Fernandez I; Herrero-González A; Andrade-Poveda M
    J Steroid Biochem Mol Biol; 2021 Sep; 212():105928. PubMed ID: 34091026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.